Bumetanide Injection
Product Images NDC 55154-5131

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 55154-5131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1mg Per 4ml Bag Label (E7c3c63e 3aea 4b33 B165 7c7449359674 00)

This text describes a pharmaceutical product named Bumetanide Injection, USP, containing 1 mg per 4 mL (0.25 mg/mL) in 5 single-dose vials. It is for intravenous or intramuscular use, and is non-latex. The ingredients include bumetanide, sodium chloride, ammonium acetate, edetate disodium, and benzylalcohol. The storage instructions recommend storing the product at 20° to 25° C. The package is not child-resistant and is intended for institutional use only. The product is manufactured by Hikma in Berkeley Heights, NJ and distributed by Cardinal Health in Dublin, OH.*

FDA Label Image

Structural Formula (Bumetanide Injection Usp 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.